Genetic manipulations of PPARs: Effects on obesity and metabolic disease

PPAR Research

Volumn , Issue , 2007, Pages

  Barak, Yaacov ^a   Kim, Suyeon ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37649030647     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2007/12781     Document Type: Review

References (92)

1. I. Issemann S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347 6294 1990 645 650
2. O. Braissant F. Foufelle C. Scotto M. Dauça W. Wahli Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 137 1 1996 354 366
3. S. S.-T. Lee T. Pineau J. Drago Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Molecular and Cellular Biology 15 6 1995 3012 3022
4. T. Aoyama toshifu@gipac.shinshu-u.ac.jp J. M. Peters N. Iritani Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). Journal of Biological Chemistry 273 10 1998 5678 5684
5. J. M. Peters N. Hennuyer B. Staels Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. Journal of Biological Chemistry 272 43 1997 27307 27312
6. P. Costet C. Legendre J. Moré A. Edgar P. Galtier T. Pineau tpineau@toulouse.inra.fr Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. Journal of Biological Chemistry 273 45 1998 29577 29585
7. M. E. Poynter R. A. Daynes daynes.office@path.med.utah.edu Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging. Journal of Biological Chemistry 273 49 1998 32833 32841
8. T. E. Akiyama C. J. Nicol C. Fievet Peroxisome proliferator-activated receptor-α regulates lipid homeostasis, but is not associated with obesity. Studies with congenic mouse lines. Journal of Biological Chemistry 276 42 2001 39088 39093
9. Y. Lee X. Yu F. Gonzales PPARα is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proceedings of the National Academy of Sciences of the United States of America 99 18 2002 11848 11853
10. T. C. Leone C. J. Weinheimer D. P. Kelly dkelly@imgate.wustl.edu A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: the PPARα-null mouse as a model of fatty acid oxidation disorders. Proceedings of the National Academy of Sciences of the United States of America 96 13 1999 7473 7478
11. S. Kersten J. Seydoux J. M. Peters F. J. Gonzalez B. Desvergne W. Wahli walter.wahli@iba.unil.ch Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. Journal of Clinical Investigation 103 11 1999 1489 1498
12. M. C. Sugden K. Bulmer G. F. Gibbons B. L. Knight M. J. Holness Peroxisome-proliferator-activated receptor-α (PPARα) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin. Biochemical Journal 364 2 2002 361 368
13. S. S.-T. Lee lee2022@cuhk.edu.hk W.-Y. Chan C. K. C. Lo D. C. C. Wan D. S. C. Tsang W.-T. Cheung Requirement of PPARα in maintaining phospholipid and triacylglycerol homeostasis during energy deprivation. Journal of Lipid Research 45 11 2004 2025 2037
14. J. Xu G. Xiao C. Tirujillo Peroxisome proliferator-activated receptor α (PPARα) influences substrate utilization for hepatic glucose production. Journal of Biological Chemistry 277 52 2002 50237 50244
15. R. H. J. Bandsma T. H. van Dijk A. ter Harmsel Hepatic de novo synthesis of glucose-6-phosphate is not affected in PPARα-deficient mice but is preferentially directed towards hepatic glycogen stores after a short-term fast. Journal of Biological Chemistry 279 10 2004 8930 8937
16. J. M. Huss D. P. Kelly dkelly@im.wustl.edu Nuclear receptor signaling and cardiac energetics. Circulation Research 95 6 2004 568 578
17. K. Watanabe watanabe@niigata-pharm.ac.jp H. Fujii T. Takahashi Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with age-dependent cardiac toxicity. Journal of Biological Chemistry 275 29 2000 22293 22299
18. F. Djouadi C. J. Weinheimer J. E. Saffitz A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice. Journal of Clinical Investigation 102 6 1998 1083 1091
19. B. N. Finck J. J. Lehman T. C. Leone The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. Journal of Clinical Investigation 109 1 2002 121 130
20. M. Guerre-Millo C. Rouault P. Poulain PPAR-α-null mice are protected from high-fat diet-induced insulin resistance. Diabetes 50 12 2001 2809 2814
21. C. Bernal-Mizrachi S. Weng C. Feng Dexamethasone induction of hypertension and diabetes is PPAR-α dependent in LDL receptor-null mice. Nature Medicine 9 8 2003 1069 1075
22. D. Patsouris J. K. Reddy M. Müller S. Kersten sander.kersten@wur.nl Peroxisome proliferator-activated receptor α mediates the effects of high-fat diet on hepatic gene expression. Endocrinology 147 3 2006 1508 1516
23. M. Haluzik mhalu@lf1.cuni.cz O. Gavrilova D. LeRoith Peroxisome proliferator-activated receptor-α deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic- euglycemic clamp studies. Endocrinology 145 4 2004 1662 1667
24. K. K. Islam B. L. Knight K. N. Frayn D. D. Patel G. F. Gibbons geoff.gibbons@mrl.ox.ac.uk Deficiency of PPARα disturbs the response of lipogenic flux and of lipogenic and cholesterogenic gene expression to dietary cholesterol in mouse white adipose tissue. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1734 3 2005 259 268
25. D. M. Muoio P. S. MacLean D. B. Lang Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) α knock-out mice. Evidence for compensatory regulation by PPARδ Journal of Biological Chemistry 277 29 2002 26089 26097
26. B. N. Finck C. Bernal-Mizrachi D. H. Han A potential link between muscle peroxisome proliferator-activated receptor-α signaling and obesity-related diabetes. Cell Metabolism 1 2 2005 133 144
27. C. Knauf J. Rieusset M. Foretz Peroxisome proliferator-activated receptor-α-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: role in liver and brain. Endocrinology 147 9 2006 4067 4078
28. J. M. Lehmann L. B. Moore T. A. Smith-Oliver W. O. Wilkison T. M. Willson S. A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). Journal of Biological Chemistry 270 22 1995 12953 12956
29. B. M. Forman P. Tontonoz J. Chen R. P. Brun B. M. Spiegelman R. M. Evans 15-Deoxy-Δ12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ Cell 83 5 1995 803 812
30. P. Tontonoz E. Hu B. M. Spiegelman Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79 7 1994 1147 1156
31. E. D. Rosen P. Sarraf A. E. Troy PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Molecular Cell 4 4 1999 611 617
32. W. He Y. Barak A. Hevener Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proceedings of the National Academy of Sciences of the United States of America 100 26 2003 15712 15717
33. T. Imai R. Takakuwa S. Marchand Peroxisome proliferator-activated receptor γ is required in mature white and brown adipocytes for their survival in the mouse. Proceedings of the National Academy of Sciences of the United States of America 101 13 2004 4543 4547
34. Y. Barak M. C. Nelson E. S. Ong PPARγ is required for placental, cardiac, and adipose tissue development. Molecular Cell 4 4 1999 585 595
35. J. M. Olefsky A. R. Saltiel PPARγ and the treatment of insulin resistance. Trends in Endocrinology and Metabolism 11 9 2000 362 368
36. J. Plutzky The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis. The American Journal of Cardiology 92 4, supplement 1 2003 34 41
37. M. D. Tallquist P. Soriano Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 26 2 2000 113 115
38. S. Hayashi P. Lewis L. Pevny A. P. McMahon mcmahon@mcb.harvard.edu Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mechanisms of Development 119, supplement 1 2002 S97 S101
39. N. Kubota Y. Terauchi H. Miki PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Molecular Cell 4 4 1999 597 609
40. P. D. G. Miles pmiles@ucsd.edu Y. Barak W. He R. M. Evans J. M. Olefsky Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency. Journal of Clinical Investigation 105 3 2000 287 292
41. P. D. G. Miles pmiles@ucsd.edu Y. Barak R. M. Evans J. M. Olefsky Effect of heterozygous PPARγ deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding. American Journal of Physiology - Endocrinology and Metabolism 284 3 2003 E618 E626
42. T. Yamauchi H. Waki J. Kamon Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes. Journal of Clinical Investigation 108 7 2001 1001 1013
43. T. Yamauchi J. Kamon H. Waki The mechanisms by which both heterozygous peroxisome proliferator-activated receptor γ (PPARγ) deficiency and PPARγ agonist improve insulin resistance. Journal of Biological Chemistry 276 44 2001 41245 41254
44. T. E. Akiyama S. Sakai G. Lambert Conditional disruption of the peroxisome proliferator-activated receptor γ gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Molecular and Cellular Biology 22 8 2002 2607 2619
45. J. R. Jones C. Barrick K.-A. Kim Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 102 17 2005 6207 6212
46. U. B. Pajvani M. E. Trujillo T. P. Combs Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nature Medicine 11 7 2005 797 803
47. A. W. Norris L. Chen S. J. Fisher Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones. Journal of Clinical Investigation 112 4 2003 608 618
48. A. L. Hevener W. He Y. Barak Muscle-specific Pparg deletion causes insulin resistance. Nature Medicine 9 12 2003 1491 1497
49. K. Matsusue M. Haluzik G. Lambert Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. Journal of Clinical Investigation 111 5 2003 737 747
50. O. Gavrilova oksanag@bdg10.niddk.nih.gov M. Haluzik K. Matsusue Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. Journal of Biological Chemistry 278 36 2003 34268 34276
51. E. D. Rosen erosen@bidmc.harvard.edu R. N. Kulkarni P. Sarraf Targeted elimination of peroxisome proliferator-activated receptor γ in β cells leads to abnormalities in islet mass without compromising glucose homeostasis. Molecular and Cellular Biology 23 20 2003 7222 7229
52. P. Tontonoz L. Nagy J. G. A. Alvarez V. A. Thomazy R. M. Evans PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93 2 1998 241 252
53. M. Ricote A. C. Li T. M. Willson C. J. Kelly C. K. Glass cglass@ucsd.edu The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391 6662 1998 79 82
54. A. C. Li acli@ucsd.edu K. K. Brown M. J. Silvestre T. M. Willson W. Palinski C. K. Glass Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. Journal of Clinical Investigation 106 4 2000 523 531
55. A. Chawla Y. Barak L. Nagy D. Liao P. Tontonoz R. M. Evans PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine 7 1 2001 48 52
56. A. Chawla W. A. Boisvert C.-H. Lee A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular Cell 7 1 2001 161 171
57. V. R. Babaev vladimir.babaev@vanderbilt.edu P. G. Yancey S. V. Ryzhov Conditional knockout of macrophage PPARγ increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 25 8 2005 1647 1653
58. G. Pascual M. Ricote A. Hevener Anti-inflammatory and antidiabetic roles of PPARγ in macrophages. Proceedings of Keystone Symposia: Adipogenesis, Obesity and Inflammation Vancouver, British Columbia, Canada 2006 004a
59. N. K. Hollenberg Considerations for management of fluid dynamic issues associated with thiazolidinediones. American Journal of Medicine 115 8, supplement 1 2003 111 115
60. H. Zhang A. Zhang D. E. Kohan R. D. Nelson F. J. Gonzalez T. Yang tanxin.yang@hsc.utah.edu Collecting duct-specific deletion of peroxisome proliferator-activated receptor γ blocks thiazolidinedione-induced fluid retention. Proceedings of the National Academy of Sciences of the United States of America 102 26 2005 9406 9411
61. Y. Guan C. Hao D. R. Cha Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption. Nature Medicine 11 8 2005 861 866
62. C. J. Nicol M. Adachi T. E. Akiyama F. J. Gonzalez fjgonz@helix.nih.gov PPARγ in endothelial cells influences high fat diet-induced hypertension. American Journal of Hypertension 18 4 2005 549 556
63. S. Z. Duan C. Y. Ivashchenko M. W. Russell D. S. Milstone milstone@rascal.med.harvard.edu R. M. Mortensen rmort@umich.edu Cardiomyocyte-specffic knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice. Circulation Research 97 4 2005 372 379
64. S. A. Kliewer B. M. Forman B. Blumberg Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences of the United States of America 91 15 1994 7355 7359
65. P. Tontonoz E. Hu R. A. Graves A. I. Budavari B. M. Spiegelman mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes and Development 8 10 1994 1224 1234
66. J. Zhang M. Fu T. Cui Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America 101 29 2004 10703 10708
67. G. Medina-Gomez S. Virtue C. Lelliott The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-γ2 isoform. Diabetes 54 6 2005 1706 1716
68. H. Koutnikova T.-A. Cock M. Watanabe Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPARγ hypomorphic mice. Proceedings of the National Academy of Sciences of the United States of America 100 24 2003 14457 14462
69. I. Barroso M. Gurnell V. E. F. Crowley Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 6764 1999 880 883
70. A. K. Agarwal A. Garg A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy. Journal of Clinical Endocrinology and Metabolism 87 1 2002 408 411
71. R. A. Hegele hegele@robarts.ca H. Cao C. Frankowski S. T. Mathews T. Leff PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 51 12 2002 3586 3590
72. D. B. Savage M. Agostini I. Barroso Digenic inheritance of severe insulin resistance in a human pedigree. Nature Genetics 31 4 2002 379 384
73. M. Gurnell D. B. Savage V. K. K. Chatterjee kkc1@mole.bio.cam.ac.uk S. O'Rahilly sorahill@hgmp.mrc.ac.uk The metabolic syndrome: peroxisome proliferator-activated receptor γ and its therapeutic modulation. Journal of Clinical Endocrinology and Metabolism 88 6 2003 2412 2421
74. Y.-S. Tsai H.-J. Kim N. Takahashi Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ Journal of Clinical Investigation 114 2 2004 240 249
75. B. D. Freedman E.-J. Lee Y. Park J. L. Jameson ljameson@northwestern.edu A dominant negative peroxisome proliferator-activated receptor-γ knock-in mouse exhibits features of the metabolic syndrome. Journal of Biological Chemistry 280 17 2005 17118 17125
76. E. Hu J. B. Kim P. Sarraf B. M. Spiegelman Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ Science 274 5295 1996 2100 2103
77. M. Ristow D. Muller-Wieland A. Pfeiffer W. Krone C. R. Kahn Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. New England Journal of Medicine 339 14 1998 953 959
78. S. S. Deeb deeb@genetics.washington.edu L. Fajas M. Nemoto A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nature Genetics 20 3 1998 284 287
79. D. Altshuler J. N. Hirschhorn M. Klannemark The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 26 1 2000 76 80
80. S. M. Rangwala B. Rhoades J. S. Shapiro Genetic modulation of PPARγ phosphorylation regulates insulin sensitivity. Developmental Cell 5 4 2003 657 663
81. Y. Barak D. Liao W. He Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer. Proceedings of the National Academy of Sciences of the United States of America 99 1 2002 303 308
82. A. Chawla C.-H. Lee Y. Barak PPARδ is a very low-density lipoprotein sensor in macrophages. Proceedings of the National Academy of Sciences of the United States of America 100 3 2003 1268 1273
83. K. Nadra S. I. Anghel E. Joye Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor β/δ Molecular and Cellular Biology 26 8 2006 3266 3281
84. J. M. Peters jmp21@psu.edu S. S.-T. Lee W. Li Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ). Molecular and Cellular Biology 20 14 2000 5119 5128
85. M. Schuler F. Ali C. Chambon PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metabolism 4 5 2006 407 414
86. T. E. Akiyama G. Lambert C. J. Nicol Peroxisome proliferator-activated receptor β/δ regulates very low density lipoprotein production and catabolism in mice on a Western diet. Journal of Biological Chemistry 279 20 2004 20874 20881
87. Y.-X. Wang C.-H. Lee S. Tiep Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113 2 2003 159 170
88. Y.-X. Wang C.-L. Zhang R. T. Yu Regulation of muscle fiber type and running endurance by PPARδ PLoS Biology 2 10 2004 e294
89. S. Luquet J. Lopez-Soriano D. Holst Peroxisome proliferator-activated receptor δ controls muscle development and oxidative capability. FASEB Journal 17 15 2003 2299 2301
90. C.-H. Lee P. Olson A. Hevener PPARδ regulates glucose metabolism and insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America 103 9 2006 3444 3449
91. L. Cheng G. Ding Q. Qin Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nature Medicine 10 11 2004 1245 1250
92. C.-H. Lee A. Chawla N. Urbiztondo Transcriptional repression of atherogenic inflammation: modulation by PPARδ Science 302 5644 2003 453 457